Performance characteristics of the COBAS AMPLICOR Hepatitis C Virus MONITOR Test, version 2.0

American Journal of Clinical Pathology

Volumn 114, Issue 2, 2000, Pages 180-187

  Erali, M ^a   Ashwood, E R ^a   Hillyard, D R ^a  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

COBAS AMPLICOR HCV MONITOR test, version 2.0; HCV RNA quantitation; Hepatitis C virus; QUANTIPLEX HCV bDNA test

Indexed keywords

COMPLEMENTARY DNA; VIRUS DNA; VIRUS RNA;

ACCURACY; ARTICLE; CONTROLLED STUDY; DEVICE; DILUTION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; PERFORMANCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REGRESSION ANALYSIS; VIRUS DETECTION;

EVALUATION STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0034522570     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/KAJF-DL9G-0PNB-0FYH     Document Type: Article

References (15)

1. Sequence variability in the 5′ non-coding region of hepatitis C virus: Identification of a new virus type and restrictions on sequence diversity
2. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: Comparison with classifications based upon sequence similarity
3. National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C
4. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by Quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method
5. Comparison of quantitative HCV RNA assays in chronic hepatitis C
6. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays
7. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon
8. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
9. Factors predictive of a beneficial response to therapy of hepatitis C
10. Genotypic analysis of hepatitis C virus in American patients
11. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C
12. Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor Test and the Quantiplex HCV RNA 2.0 Assay (bDNA)
13. Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays
14. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison
15. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA